BioCardia Announces New U.S. Patent Covering CardiAMP Cell Therapy and Issuance of Two Asian Patents Covering Radial Artery Approach for Cardiac Cell and Gene Therapy Delivery
January 08, 2020 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Jan. 08, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioCardia Reports 2019 Third Quarter Financial Results and Business Highlights
November 19, 2019 17:24 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioCardia to Present at Dawson James Securities 5th Annual Small Cap Growth Conference
October 28, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Oct. 28, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioCardia Receives CE Mark Renewal For Helix Biotherapeutic Delivery Catheter And Morph Guide Catheter Through May 2024
October 08, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Oct. 08, 2019 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
BioCardia Announces the Appointment of Two New Board Members
October 02, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Oct. 02, 2019 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the...
BioCardia Initiates Commercial Release of AVANCE Steerable Introducer Designed to Enhance Physician Control for Complex Cardiac Procedures
October 01, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the...
BioCardia Announces Positive DSMB Recommendation to Continue Phase 3 Pivotal CardiAMP Heart Failure Study as Planned
September 16, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
BioCardia Reports 2019 Second Quarter Financial Results and Business Highlights
August 21, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioCardia Announces Issuance of European Patent for Breakthrough Diagnostic Assay for Patient Selection Prior to Cardiac Cell Therapy Delivery
August 08, 2019 08:30 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
BioCardia Announces Closing of $10.0 Million Public Offering
August 06, 2019 16:05 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NasdaqCM: BCDA, BCDAW), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...